Novartis AG (NOVN) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.092x

Based on the latest financial reports, Novartis AG (NOVN) has a cash flow conversion efficiency ratio of 0.092x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF3.60 Billion ≈ $4.55 Billion USD) by net assets (CHF39.04 Billion ≈ $49.36 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Novartis AG worth for the company's overall valuation and market capitalisation.

Novartis AG - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Novartis AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Novartis AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Novartis AG ranked by their cash flow conversion efficiency. Explore NOVN cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
BHP Group Ltd AU:BHP	0.172x
Siemens Aktiengesellschaft XETRA:SIE	0.058x
BHP Group MX:BHPN	0.061x
International Business Machines NYSE:IBM	0.075x
Citigroup Inc. NYSE:C	-0.103x
American Express Company NYSE:AXP	0.112x
Linde plc Ordinary Shares NASDAQ:LIN	0.056x
LOREAL ADR 1/5/EO 02 F:LORA	N/A

Annual Cash Flow Conversion Efficiency for Novartis AG (1998–2025)

The table below shows the annual cash flow conversion efficiency of Novartis AG from 1998 to 2025. View latest Novartis AG stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF46.52 Billion ≈ $58.81 Billion	CHF20.05 Billion ≈ $25.35 Billion	0.431x	+7.97%
2024-12-31	CHF44.13 Billion ≈ $55.79 Billion	CHF17.62 Billion ≈ $22.28 Billion	0.399x	+29.11%
2023-12-31	CHF46.75 Billion ≈ $59.10 Billion	CHF14.46 Billion ≈ $18.28 Billion	0.309x	+29.09%
2022-12-31	CHF59.42 Billion ≈ $75.13 Billion	CHF14.24 Billion ≈ $18.00 Billion	0.240x	+7.81%
2021-12-31	CHF67.82 Billion ≈ $85.75 Billion	CHF15.07 Billion ≈ $19.05 Billion	0.222x	-7.75%
2020-12-31	CHF56.67 Billion ≈ $71.64 Billion	CHF13.65 Billion ≈ $17.26 Billion	0.241x	-1.79%
2019-12-31	CHF55.55 Billion ≈ $70.23 Billion	CHF13.62 Billion ≈ $17.23 Billion	0.245x	+35.24%
2018-12-31	CHF78.69 Billion ≈ $99.49 Billion	CHF14.27 Billion ≈ $18.04 Billion	0.181x	+6.67%
2017-12-31	CHF74.23 Billion ≈ $93.84 Billion	CHF12.62 Billion ≈ $15.96 Billion	0.170x	+10.97%
2016-12-31	CHF74.89 Billion ≈ $94.68 Billion	CHF11.47 Billion ≈ $14.51 Billion	0.153x	-0.67%
2015-12-31	CHF77.12 Billion ≈ $97.50 Billion	CHF11.90 Billion ≈ $15.04 Billion	0.154x	-21.36%
2014-12-31	CHF70.84 Billion ≈ $89.57 Billion	CHF13.90 Billion ≈ $17.57 Billion	0.196x	+10.89%
2013-12-31	CHF74.47 Billion ≈ $94.15 Billion	CHF13.17 Billion ≈ $16.66 Billion	0.177x	-13.68%
2012-12-31	CHF69.26 Billion ≈ $87.57 Billion	CHF14.19 Billion ≈ $17.95 Billion	0.205x	-5.56%
2011-12-31	CHF65.94 Billion ≈ $83.37 Billion	CHF14.31 Billion ≈ $18.09 Billion	0.217x	+7.63%
2010-12-31	CHF69.77 Billion ≈ $88.21 Billion	CHF14.07 Billion ≈ $17.78 Billion	0.202x	-4.97%
2009-12-31	CHF57.46 Billion ≈ $72.65 Billion	CHF12.19 Billion ≈ $15.41 Billion	0.212x	+9.54%
2008-12-31	CHF50.44 Billion ≈ $63.77 Billion	CHF9.77 Billion ≈ $12.35 Billion	0.194x	+3.88%
2007-12-31	CHF49.40 Billion ≈ $62.45 Billion	CHF9.21 Billion ≈ $11.64 Billion	0.186x	-11.60%
2006-12-31	CHF41.29 Billion ≈ $52.21 Billion	CHF8.71 Billion ≈ $11.01 Billion	0.211x	-13.43%
2005-12-31	CHF33.16 Billion ≈ $41.93 Billion	CHF8.08 Billion ≈ $10.22 Billion	0.244x	+13.45%
2004-12-31	CHF31.32 Billion ≈ $39.59 Billion	CHF6.72 Billion ≈ $8.50 Billion	0.215x	-1.47%
2003-12-31	CHF30.52 Billion ≈ $38.58 Billion	CHF6.65 Billion ≈ $8.41 Billion	0.218x	+5.93%
2002-12-31	CHF28.34 Billion ≈ $35.82 Billion	CHF5.83 Billion ≈ $7.37 Billion	0.206x	+18.68%
2001-12-31	CHF25.56 Billion ≈ $32.31 Billion	CHF4.43 Billion ≈ $5.60 Billion	0.173x	-14.50%
2000-12-31	CHF22.89 Billion ≈ $28.94 Billion	CHF4.64 Billion ≈ $5.87 Billion	0.203x	+9.95%
1999-12-31	CHF23.51 Billion ≈ $29.72 Billion	CHF4.33 Billion ≈ $5.48 Billion	0.184x	-1.03%
1998-12-31	CHF22.96 Billion ≈ $29.02 Billion	CHF4.28 Billion ≈ $5.41 Billion	0.186x	--

About Novartis AG

SW:NOVN Switzerland Drug Manufacturers - General

Market Cap

$279.88 Billion

CHF221.38 Billion CHF

Market Cap Rank

#95 Global

#3 in Switzerland

Share Price

CHF116.02

Change (1 day)

+1.52%

52-Week Range

CHF97.52 - CHF131.32

All Time High

CHF131.32